Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Alpha-lipoic acid and docosahexaenoic acid

A positive interaction on the carrageenan inflammatory response in rats

  • 52 Accesses

  • 3 Citations

Summary

Peripheral nerves are subject to the same types of problems as other tissues: inflammation, toxicity, swelling, permeability, leading to neuropathies. Nutrients offer an alternative for people who want to avoid the side effects of prescription drugs.

These studies were designed to assess the pharmacodynamic interaction between alpha-lipoic acid (ALA) and docosahexaenoic acid (DHA) in controlling the inflammatory response induced by carrageenan in the rat. Particularly, the activity of ALA (100 mg/kg per os) and DHA (200 mg/kg per os), given alone or in combination, was evaluated by paw oedema method.

The results of the present study clearly indicate that the new formulation containing ALA plus DHA, in a range of 2:1, had significantly greater effect than either DHA or ALA alone in antagonizing carrageenan-induced inflammatory response.

These results indicate that ALA plus DHA induce a favourable pharmacodynamic interaction which can be considered to be synergistic, at least in these experimental settings.

This is a preview of subscription content, log in to check access.

References

  1. 1

    Minis MA, Heerkens Y, Engels J, Oostendorp R, van Engelen B (2009) Classification of employment factors according to the International Classification of Functioning, Disability and Health in patients with neuromuscular diseases: a systematic review Disabil Rehabil 31 2150–2163

  2. 2

    Packer L, Witt EH, Tritschler HJV (1995) Alpha-lipoic acid as a biological antioxidant Free Radic Biol Med 19 227–250

  3. 3

    Vincent HK, Bourguignon CM, Vincent KR, Taylor AG (2007) Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot study J Alt Complement Med 13 577–584

  4. 4

    Packer L, Tritschler HJ, Wessel K (1997) Neuroprotection by the metabolic antioxidant alpha-lipoic acid Free Radic Biol Med 22 359–378

  5. 5

    Teichert J, Kern J, Tritschler HJ (1998) Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers Int J Clin Pharmacol Ther 36 625–628

  6. 6

    Beitner H (2003) Randomized, placebo controlled, double-blind study on the clinical efficacy of a cream containing 5% alpha-lipoic acid related to photoaging of facial skin Br J Dermatol 149 841–849

  7. 7

    Teichert J, Hermann R, Ruus P, Preiss R (2003) Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers J Clin Pharmacol 43 1257–1267

  8. 8

    Biewenga GP, Haenen GR, Bast A (1997) The pharmacology of the antioxidant lipoic acid Gen Pharmacol 29 315–331

  9. 9

    Packer L (1994) Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts Ann NY Acad Sci USA 738 257–264

  10. 10

    Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N et al SYDNEY Trial Study Group (2003) The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid Diabetes Care 26 770–776

  11. 11

    Block G, Jensen C, Dietrich M, Norkus EP, Hudes M, Packer L (2004) Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation J Am Coll Nutr 23 141–147

  12. 12

    Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA et al (1995) Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy Diabetes Care 18 1160–1167

  13. 13

    Kishi Y, Schmelzer JD, Yao JK, Zollman PJ, Nickander KK et al (1999) Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy Diabetes 48 2045–2051

  14. 14

    Haramaki N, Assadnazari H, Zimmer G, Schepkin V et al (1995) The influence of vitamin E and dihydrolipoic acid on cardiac energy and glutathione status under hypoxia-reoxygenation Biochem Mol Biol Int 37 591–597

  15. 15

    Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH (1998) Alpha-lipoic acid in liver metabolism and disease Free Radic Biol Med 24 1023–1039

  16. 16

    Spector AA (1999) Essentiality of fatty acids Lipids 34 S1–S3

  17. 17

    Singh M (2005) Essential fatty acids, DHA and human brain Indian J Pediatr 72 239–242

  18. 18

    Lim GP, Calon F, Morihara T, Yang F, Teter B et al (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model J Neurosci 25 3032–3040

  19. 19

    Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O (2005) Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid betainfused rats J Nutr 135 549–555

  20. 21

    De Caterina R, Liao JK, Libby P (2000) Fatty acid modulation of endothelial activation Am J Clin Nutr 71 213S–223S

  21. 22

    Olsen SF, Hansen HS, Sørensen TI, Jensen B, Secher NJ et al (1986) Intake of marine fat, rich in (n-3)-polyunsaturated fatty acids, may increase birth weight by prolonging gestation Lancet 2 367–369

  22. 23

    Winter CA, Risly EA, Nuss CW (1962) Carrageenan induced edema in hind paw of the rats an assay for anti-inflammatory drugs Proc Soc Exp Biol Med 111 544–547

  23. 24

    Van Arman CG, Begany AJ, Miller LM, Pless HH (1965) Some details of the inflammations caused by yeast and carrageenan (with appendix on the kinetics of the reaction) J Pharmacol Exp Ther 150 328–334

  24. 25

    Purves R (1992) Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the moment-curve (AUMC) J Pharmacokinet Biopharm 20 211–226

  25. 26

    Shenawy SM, Abdel-Salam OM, Baiuomy AR, Baeran SE, Arbid MS (2002) Studies on the Anti-inflammatory and Anti-nociceptive effects of melatonin in rat Pharmacol Res 46 235–243

  26. 27

    Higgs GA, Harvey EA, Ferreira SH, Vane JR (1976) The effects of anti-inflammatory drugs on the production of prostaglandins in vivo Adv Prostaglandin Thromboxane Res 1 105–110

  27. 28

    Gilligan JP, Lovato SJ, Erion MD, Jeng AY (1994) Modulation of carrageenan-induced hind paw edema by substance P Inflammation 18 285–292

  28. 29

    Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM et al (1996) Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation Br J Pharmacol 118 829–838

  29. 30

    Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM (2009) Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential Biochim Biophys Acta 1790 1149–1160

  30. 31

    Lee EY, Lee CK, Lee KU, Park JY, Cho KJ et al (2007) Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice Rheumatol Int 27 225–233

  31. 32

    Hah YS, Sung MJ, Lim HS, Jun JS, Jeong YG et al (2010) Dietary alpha lipoic acid supplementation prevents synovial inflammation and bone destruction in collagen-induced arthritic mice Rheumatol Int DOI 10.1007/s00296-010-1505-3

  32. 33

    Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M et al (1995) Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study) Diabetologia 38 1425–1433

  33. 34

    Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K et al (1999) Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized doubleblind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy Free Radic Res 31 171–179

  34. 35

    Sijben JW, Calder PC (2007) Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease Proc Nutr Soc 66 237–259

  35. 36

    Corey EJ, Shih C, Cashman JR (1983) Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis Proc Natl Acad Sci USA 80 3581–3584

  36. 37

    Richard D, Wolf C, Barbe U, Kefi K, Bausero P, Visioli F (2009) Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathway Biochem Biophys Res Commun 389 516–522

  37. 38

    Michael-Titus AT (2007) Omega-3 fatty acids and neurological injury Prostaglandins Leukot Essent Fatty Acids 77 295–300

  38. 39

    Stankov BM (2007) Deposito d’invenzione industriale MI2007A001356. Nuove formulazioni contenenti acidi grassi essenziali e composti tiolici

  39. 40

    Amenta F, Traini E, Tomassoni D, Mignini F (2008) Pharmacokinetics of different formulations of tioctic (alpha-lipoic) acid in healthy volunteers Clin Exp Hypertens 30 767–775

Download references

Author information

Correspondence to Giuseppe Rossoni.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rossoni, G., Stankov, B.M. Alpha-lipoic acid and docosahexaenoic acid. Nutrafoods 9, 21–25 (2010). https://doi.org/10.1007/BF03223338

Download citation

Keywords

  • Docosahexaenoic Acid
  • Diabetic Neuropathy
  • Lipoic Acid
  • Diabetic Peripheral Neuropathy
  • Alpha Lipoic Acid